Cardinal Health (CAH) Tops Q1 EPS by 4c

Cardinal Health (NYSE: CAH) reported Q1 EPS of $1.00, $0.04 better than the analyst estimate of $0.96. Revenue for the quarter came in at $24.1 billion versus the consensus estimate of $22.43 billion.

Cardinal Health sees FY2014 EPS of $4.10-$4.30, versus the consensus of $4.24.

"Fiscal year 2015 is off to a good start. Our organization has committed itself to anticipating and acting on the evolving needs of a fast-changing market," said George Barrett, chairman and chief executive officer of Cardinal Health. "Both segments reported solid earnings growth and progress on all strategic fronts. Our Pharmaceutical segment continued its momentum, and we are excited about the potential from Red Oak Sourcing, our generic sourcing joint venture with CVS Health. The Medical segment continued its growth with strategic accounts and our direct-to-customer platforms, now rebranded as Cardinal Health at Home. Our physician preference item program addresses significant health system pain points and now spans orthopedics, interventional cardiology and wound management."

For earnings history and earnings-related data on Cardinal Health (CAH) click here.

You May Also Be Interested In

• Tesla stock up as automotive gross margin improves, free cash flow turns positive
• Oak Valley Bancorp (OVLY) Tops Q3 EPS by 77c
• Medpace beats Q3 estimates but guides below on revenue